The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
Texas MPN Workshop 2022 | The role of allogeneic transplant in myelofibrosis and important factors to consider
Jeanne Palmer, MD, Mayo Clinic, Phoenix, AZ, discusses the role of allogeneic stem cell transplantation (alloSCT) in the treatment of myelofibrosis (MF), highlighting important factors to consider when selecting patients for transplant. Dr Palmer then comments on donor selection, and further explains various methods that may be followed to manage splenomegaly. To conclude, Dr Palmer shares some insights into how novel therapies may affect the role and timing of transplant in MF. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.
